Zim Laboratories Ltd. (ZIMLA) 52 Week High Streak: Consecutive High Analysis
- October 12, 2026
- Posted by: Chaitanya Auti
- Category: News
Zim Laboratories Ltd. 52 Week High Streak has now stretched into the second straight session, with the stock trading within 2% of its one-year peak across the streak and rising 9.99% over that span. Zim Laboratories Ltd. share price was last at Rs 154.7 after touching a high of Rs 160.1, while the latest Univest data confirms the pattern but does not establish a company-specific catalyst for the continued move.
As of 12 October 2026 at 10:52 AM IST, Zim Laboratories Ltd. share price stood above the previous close of Rs 150.7, opened at Rs 154.8 and moved between Rs 152.25 and Rs 160.1. The company’s market capitalisation is Rs 808.63 crore. For readers tracking Zim Laboratories Ltd. 52 Week High Streak, the key point is not a single-day move alone but the fact that the stock has stayed near its yearly high for more than one session, which keeps Zim Laboratories Ltd. Stock News in focus.
Zim Laboratories Ltd. 52 Week High Streak: Consecutive High Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 154.7 |
| Previous Close | Rs 150.7 |
| Today's Move | +Rs 4 (+2.65%) |
| Open | Rs 154.8 |
| High | Rs 160.1 |
| Low | Rs 152.25 |
| Market Capitalisation | Rs 808.63 crore |
Zim Laboratories Ltd. (ZIMLA) traded at Rs 154.7 versus the previous close of Rs 150.7, a rise of 2.65%. The stock opened at Rs 154.8, reached a high of Rs 160.1 and touched a low of Rs 152.25.
Zim Laboratories Ltd. share price is trading at Rs 154.7, up Rs 4 or 2.65% versus the previous close of Rs 150.7. The day began at Rs 154.8, moved to a high of Rs 160.1 and a low of Rs 152.25, placing the stock in the upper half of its intraday range at the time of observation. With a market capitalisation of Rs 808.63 crore, Zim Laboratories Ltd. Share Price Today remains closely watched by readers looking at 52 Week High Stocks and broader Stock Performance. The session detail matters because it shows that the current price action is occurring near the upper end of the day’s band while the wider streak context points to persistence near the one-year peak. That combination is why Zim Laboratories Ltd. Share Price Update searches often rise when the stock repeatedly trades close to its 52-week high. For investors scanning Stocks In News Today, the emphasis here is the pattern, not a fresh record claim.
Zim Laboratories Ltd. 52 Week High Streak: Consecutive High Analysis
Zim Laboratories Ltd. 52 Week High Streak now covers a second straight session, and that repeated pattern is the main story. Across the streak, the stock has moved 9.99%, which makes the current run more relevant than a single intraday print near the one-year high. Zim Laboratories Ltd. New One Year High searches often pick up around such moves, but in this case the key fact is that the share has remained within 2% of its 52-week high on consecutive sessions rather than simply touching the level once. That is why Zim Laboratories Ltd. Consecutive 52 Week High searches can reflect sustained price proximity to the peak, not just a brief breakout headline. The latest figures confirm the pattern, yet they do not identify a stock-specific trigger. In practical terms, the streak tells readers that Zim Laboratories Ltd. Share Price has stayed in a tight zone near its yearly top, which keeps the stock on lists of Stocks At One Year High Today and Stocks Hitting 52 Week Highs.
What the Repeated 52-Week Highs Show
Repeated near-high sessions usually matter because they show persistence around a known reference point, and that is the central read for Zim Laboratories Ltd. 52 Week High For second straight session. The latest information shows that the stock has not only stayed close to its one-year high, but has also done so across multiple sessions, which is a different signal from a one-off move in Zim Laboratories Ltd. Share Price. For readers asking why Zim Laboratories Ltd. Back To Back 52 Week Highs matter, the answer is simple: the streak keeps the share under market attention and makes each new session relevant to the prior one. At the same time, the data does not confirm any fresh business announcement, earnings trigger or sector event behind the move. That distinction is important for anyone following Stocks In News Today or screening Stocks Hitting 52 Week Highs, because the pattern itself is real even when the reason behind it is not established. In other words, Zim Laboratories Ltd. Stock News currently reflects a sustained price pattern, not a verified catalyst.
Zim Laboratories Ltd. (ZIMLA) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 808.63 crore |
| P/E Ratio | 218.79x |
| P/B Ratio | 2.78x |
| ROE | 2.14% |
| ROCE | 5.47% |
| EPS | Rs 0.69 |
| Book Value Per Share | Rs 54.16 |
| Dividend Yield | 0% |
Zim Laboratories Ltd. (ZIMLA) fundamental metrics show P/E 218.79x, P/B 2.78x, ROE 2.14%, ROCE 5.47%. These figures provide context only and are not a buy or sell signal.
Zim Laboratories Ltd. has a market capitalisation of Rs 808.63 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 218.79x, P/B at 2.78x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 2.14% and ROCE of 5.47%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 0.69, book value per share of Rs 54.16, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 27.01x, median ROE of 11.22%, median ROCE of 13.1%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 218.79x |
| Benchmark Median P/E | 27.01x |
| Benchmark Average P/E | 38.15x |
| Benchmark P/E Range | 0x to 679.32x |
| Company P/B Ratio | 2.78x |
| Benchmark Median P/B | 2.8x |
| Company ROE | 2.14% |
| Benchmark Median ROE | 11.22% |
| Company ROCE | 5.47% |
| Benchmark Median ROCE | 13.1% |
| Company Market Capitalisation | Rs 808.63 crore |
| Benchmark Median Market Cap | Rs 684.83 crore |
Zim Laboratories Ltd. (ZIMLA) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Zim Laboratories Ltd. (ZIMLA) has a P/E ratio of 218.79x, which is above the benchmark median of 27.01x, a difference of +710.03%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Zim Laboratories Ltd. (ZIMLA) has a ROE of 2.14%, which is below the benchmark median of 11.22%, a difference of -80.93%. Zim Laboratories Ltd. (ZIMLA) has a ROCE of 5.47%, which is below the benchmark median of 13.1%, a difference of -58.24%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Anuh Pharma Ltd. | ANUHPHR | 817.53 | 18.51 | 2.25 | 12.1 | 16.02 |
| Kilitch Drugs (India) Ltd. | KILITCH | 848.52 | 28.23 | 3.02 | 12.26 | 14.5 |
| HEXAGON NUTRITION LIMITED | HEXAGON | 848.63 | 22.37 | 3.68 | 18.82 | 22.79 |
| Shree Ganesh Remedies Ltd. | SGRL | 874.56 | 56.66 | 5.33 | 11.53 | 14.63 |
| Amanta Healthcare Ltd. | AMANTA | 734.46 | 50.04 | 3.29 | 9.4 | 11.23 |
Zim Laboratories Ltd. (ZIMLA) has a P/E ratio of 218.79x compared with the displayed peer median of 28.23x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 2.14% compares with a peer median of 12.1% across the companies shown in the table. ROCE stood at 5.47% versus the displayed peer median of 14.63%, providing a capital-efficiency comparison. Zim Laboratories Ltd. (ZIMLA) has a market capitalisation of Rs 808.63 crore. Among the 5 peers shown, 4 have a larger market capitalisation.
Why Investors Are Watching Zim Laboratories Ltd.
- Zim Laboratories Ltd. 52 Week High Streak has continued for a second straight session, keeping the stock on the radar of readers tracking Stocks At One Year High Today.
- The cumulative move across the streak is 9.99%, which makes the pattern more notable than a single-day rise in Zim Laboratories Ltd. Share Price.
- Zim Laboratories Ltd. Share Price is trading near its one-year high, so the stock remains part of the broader Stocks Hitting 52 Week Highs list.
- The latest figures do not confirm a company-specific catalyst, which makes Zim Laboratories Ltd. Stock News a pattern-led story rather than a trigger-led one.
- The stock’s P/E of 218.79 is far above the industry median, so Zim Laboratories Ltd. Fundamental Analysis stays central to the current debate.
About Zim Laboratories Ltd.
Zim Laboratories Ltd. operates in the Pharmaceuticals & Drugs industry within the Healthcare sector. With a market capitalisation of Rs 808.63 crore, the company is part of a peer group that includes several similarly sized listed names. Zim Laboratories Ltd. share price has therefore become a focal point for readers following Zim Laboratories Ltd. Company News, Zim Laboratories Ltd. Stock Performance and Zim Laboratories Ltd. Share Price Today. The latest streak keeps the stock in discussion, but the broader reading still depends on valuation, earnings quality and sector comparison rather than on the streak alone. For investors monitoring Zim Laboratories Ltd. Market Cap and company financials, the current setup combines a near-high price pattern with a premium earnings multiple.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Registration Number INH000013776), a subsidiary of Univest Communication Technologies Private Limited.
Frequently Asked Questions
What does Zim Laboratories Ltd. 52 Week High Streak mean?
Ans. It means Zim Laboratories Ltd. has traded within 2% of its 52-week high for consecutive sessions. In this case, the streak has lasted for a second straight session, which keeps Zim Laboratories Ltd. Share Price in focus.
How much has Zim Laboratories Ltd. moved across the streak?
Ans. According to the latest Univest figures, Zim Laboratories Ltd. has moved 9.99% across the streak. That cumulative move is the main differentiator from a simple one-day near-high event.
Did Zim Laboratories Ltd. set a new 52-week high today?
Ans. No claim is being made that a new 52-week high was set. The available market data shows the stock trading near its one-year peak, not necessarily breaking above it.
Why is Zim Laboratories Ltd. still in the news after the first breakout?
Ans. Because the stock has kept trading close to its 52-week high for more than one session. Zim Laboratories Ltd. Stock News stays relevant when the price pattern persists rather than appearing once.
Is there a company-specific reason for the move in Zim Laboratories Ltd. Share Price?
Ans. The latest Univest data confirms the price pattern, but it does not establish a company-specific catalyst. Readers should treat the streak as a market observation first and a reasoned event only when a trigger is confirmed.
How does Zim Laboratories Ltd. compare with peers on valuation?
Ans. Zim Laboratories Ltd. trades at a far higher P/E than the industry median, while its P/B is close to the peer-group midpoint. That makes Zim Laboratories Ltd. Fundamental Analysis especially important right now.
Why do investors track stocks hitting 52 week highs?
Ans. Investors track these names because repeated proximity to a yearly peak often attracts attention and can keep a stock in market discussions. In Zim Laboratories Ltd.’s case, the streak is the key event, not just the day’s move.
What should investors monitor next for Zim Laboratories Ltd.?
Ans. Monitor whether Zim Laboratories Ltd. Share Price continues to stay near its one-year peak, and whether company filings, results or sector developments provide a clear reason for the pattern. The streak itself is confirmed; the trigger is not.
Track Zim Laboratories Ltd. (ZIMLA) Share Price on Univest
Use Zim Laboratories Ltd. (ZIMLA) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.